MAP2K1 and acute lymphoblastic leukemia: The xenograft cells showed sensitivity to the MEK1/2 inhibitor, selumetinib, in vitro. A cell line model is not available for iAMP21-ALL and, due to the rarity of this disease, only limited iAMP21-ALL xenograft material was available.